142384-07-4 Usage
General Description
2-[(3-methyl-4-nitro-2-pyridyl)methylsulfinyl]-1H-benzimidazole, also known as omeprazole, is a proton pump inhibitor used to reduce stomach acid production and treat conditions such as gastroesophageal reflux disease (GERD), stomach ulcers, and Zollinger-Ellison syndrome. Omeprazole works by blocking the enzyme in the stomach wall that produces acid, thereby reducing the amount of acid in the stomach. It is a commonly prescribed medication and is available over-the-counter in some countries. Omeprazole is generally well-tolerated, with potential side effects including headache, nausea, and diarrhea. It is important to follow the prescribed dosage and duration of treatment to avoid potential adverse effects.
Check Digit Verification of cas no
The CAS Registry Mumber 142384-07-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,3,8 and 4 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 142384-07:
(8*1)+(7*4)+(6*2)+(5*3)+(4*8)+(3*4)+(2*0)+(1*7)=114
114 % 10 = 4
So 142384-07-4 is a valid CAS Registry Number.
142384-07-4Relevant articles and documents
An efficient synthesis of dexlansoprazole employing asymmetric oxidation strategy
Raju, Manne Naga,Kumar, Neelam Uday,Reddy, Baddam Sudhakar,Anitha, Naredla,Srinivas, Gangula,Bhattacharya, Apurba,Mukkanti, Kagga,Kolla, Naveenkumar,Bandichhor, Rakeshwar
supporting information; experimental part, p. 5464 - 5466 (2011/11/01)
An alternative and scalable synthesis of dexlansoprazole ((R)-(+)-1); the (R)-enantiomer of Lansoprazole with an enantiomeric excess of >99.8% is presented.
DEXLANSOPRAZOLE PROCESS AND POLYMORPHS
-
Page/Page column 55, (2009/10/22)
Processes for the preparation of dexlansoprazole, an amorphous form of dexlansoprazole, a solid dispersion of amorphous dexlansoprazole and a pharmaceutically acceptable carrier, and processes for their preparation. Also provided are crystalline compounds 2-[(R)-[(4-chloro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole and 2-[(R)-[(4-nitro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, and methods for their preparation.
